Leveraging Large Language Models to Predict Antibody Biological Activity Against Influenza A Hemagglutinin

Ella Barkan, Ibrahim Siddiqui, Kevin J. Cheng +6

Monoclonal antibodies (mAbs) represent one of the most prevalent FDA-approved modalities for treating autoimmune diseases, infectious diseases, and cancers. However, discovery and…